2018
DOI: 10.1016/j.jad.2017.11.009
|View full text |Cite
|
Sign up to set email alerts
|

Identifying relapse prevention elements during psychological treatment of depression: Development of an observer-based rating instrument

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…On the other hand, competence instruments were published for specific diagnoses (Machmutow, grosse Holtforth, Krieger, & Watzke, 2018;von Consbruch, Clark, & Stangier, 2012), differentiated subscales on generic and CBT-specific competences (Roth, 2016), or coverage of circumscribed interventions such as case conceptualizations (Kuyken et al, 2016) or relapse prevention (Machmutow et al, 2018). Although the improvement of current instruments should be given priority, it is also reasonable to specify knowledgebased from skills-based measures of competence (Muse & McManus, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, competence instruments were published for specific diagnoses (Machmutow, grosse Holtforth, Krieger, & Watzke, 2018;von Consbruch, Clark, & Stangier, 2012), differentiated subscales on generic and CBT-specific competences (Roth, 2016), or coverage of circumscribed interventions such as case conceptualizations (Kuyken et al, 2016) or relapse prevention (Machmutow et al, 2018). Although the improvement of current instruments should be given priority, it is also reasonable to specify knowledgebased from skills-based measures of competence (Muse & McManus, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Some patients may feel better and think they no longer need the medication, or stop their medicine because of bothersome side effects, without consulting their doctors. Premature withdrawal of treatment often led to increases relapse and recurrence rates, which were found to be high . The 2‐year recurrence rate is about 40% after the first episode, and after two episodes, the risk of recurrence at 5 years reaches 75% .…”
Section: Introductionmentioning
confidence: 99%
“…Premature withdrawal of treatment often led to increases relapse and recurrence rates, which were found to be high. [8][9][10] The 2-year recurrence rate is about 40% after the first episode, and after two episodes, the risk of recurrence at 5 years reaches 75%. 11 Relapse and recurrence keep torturing MDD patients and increase healthcare costs.…”
Section: Introductionmentioning
confidence: 99%